Arcoma AB (ARCOMA) - Total Liabilities

Latest as of September 2025: Skr24.58 Million SEK ≈ $2.64 Million USD

Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr24.58 Million SEK (≈ $2.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Arcoma AB to assess how effectively this company generates cash.

Arcoma AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data. Check ARCOMA financial resilience to evaluate the company's liquid asset resilience ratio.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Holand og Setskog Sparebank OL:HSPG	Norway	Nkr8.13 Billion
Telecom Plus PLC LSE:TEP	UK	GBX430.89 Million
The Grob Tea Company Limited NSE:GROBTEA	India	Rs332.49 Million
Clinical Laserthermia Systems AB (publ) ST:CLS-B	Sweden	Skr10.00 Million
Yelooo Integra Datanet Tbk PT JK:YELO	Indonesia	Rp8.96 Billion
iOThree Limited Ordinary Shares NASDAQ:IOTR	USA	$4.88 Million
Cielo Waste Solutions Corp V:CMC	Canada	CA$3.53 Million
Zhibao Technology Inc. Class A Ordinary Shares NASDAQ:ZBAO	USA	$233.87 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Arcoma AB (ARCOMA) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2024)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr21.13 Million ≈ $2.27 Million	-36.56%
2023-12-31	Skr33.30 Million ≈ $3.58 Million	-38.84%
2022-12-31	Skr54.46 Million ≈ $5.86 Million	+54.57%
2021-12-31	Skr35.23 Million ≈ $3.79 Million	-22.57%
2020-12-31	Skr45.50 Million ≈ $4.90 Million	+19.28%
2019-12-31	Skr38.14 Million ≈ $4.10 Million	+2.43%
2018-12-31	Skr37.24 Million ≈ $4.01 Million	+36.52%
2017-12-31	Skr27.28 Million ≈ $2.94 Million	-19.55%
2016-12-31	Skr33.90 Million ≈ $3.65 Million	-1.26%
2015-12-31	Skr34.34 Million ≈ $3.69 Million	-8.40%
2014-12-31	Skr37.48 Million ≈ $4.03 Million	-35.77%
2013-12-31	Skr58.35 Million ≈ $6.28 Million	+31.57%
2012-12-31	Skr44.35 Million ≈ $4.77 Million	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$11.55 Million

Skr107.31 Million SEK

Market Cap Rank

#26506 Global

#571 in Sweden

Share Price

Skr7.50

Change (1 day)

+0.00%

52-Week Range

Skr6.92 - Skr10.75

All Time High

Skr25.60